ZITRO 500 MG BT 3
Product informations
They are based on the antibacterial activity and pharmacokinetic characteristics of azithromycin. They take into account both the clinical studies conducted with this medicine and its place in the range of antibacterial products currently available. They are limited to infections caused by bacteria defined as sensitive, including
- Documented streptococcus A beta-hemolytic angina, as an alternative to beta-lactam treatment, particularly when it cannot be used.
- Superinfections of acute bronchitis.
- Exacerbations of chronic bronchitis.
- Stomatological infections.
- It is important to consider the official recommendations for the appropriate use of antibacterial.